Are unregulated compounds like retatratide being sold on social media?

The continuing explosion in demand for new wight-loss drugs is raising difficult questions about how society talks about weight, and how it treats people with weight loss. Professor Donal O'Shea, endocrinologist and HSE Clinical Lead for Obesity, brings Brendan up to date.

See omnystudio.com/listener for privacy information.